Robert Azelby is Director of CARDINAL HEALTH INC. Currently has a direct ownership of 4,085 shares of CAH, which is worth approximately $838,936. The most recent transaction as insider was on Nov 05, 2025, when has been sold 1,067 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.09K
35.35% 3M change
35.35% 12M change
Total Value Held $838,936

Robert Azelby Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 05 2025
BUY
Grant, award, or other acquisition
-
1,067 Added 20.71%
4,085 Common Shares
Nov 06 2024
BUY
Grant, award, or other acquisition
-
1,730 Added 36.44%
3,018 Common Shares
Mar 15 2024
BUY
Grant, award, or other acquisition
-
1,288 Added 50.0%
1,288 Common Shares

Also insider at

KDNY
CHINOOK THERAPEUTICS, INC. Healthcare
ADCT
ADC Therapeutics SA Healthcare
CLVS
Clovis Oncology, Inc. Healthcare
ELYM
Eliem Therapeutics, Inc. Healthcare
TERN
Terns Pharmaceuticals, Inc. Healthcare
IMMU
IMMUNOMEDICS INC
RA

Robert Azelby

Director
Morris Plains, NJ

Track Institutional and Insider Activities on CAH

Follow CARDINAL HEALTH INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CAH shares.

Notify only if

Insider Trading

Get notified when an Cardinal Health Inc insider buys or sells CAH shares.

Notify only if

News

Receive news related to CARDINAL HEALTH INC

Track Activities on CAH